Publication at Faculty of Medicine in Hradec Králové |
2007
Abstract
The effects of lipid-lowering treatment were evaluated in patients with schizophrenia treated with antipsychotics. Forty-six patients with schizophrenia and with severe dyslipidaemia were examined at baseline and three months after initiation of statin therapy.
A significant decrease in triglycerides, total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and in associated ratios was observed. No significant changes occurred in components of metabolic syndrome other that triglycerides